Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
depatuxizumab mafodotin
×
Sarcoma
×
Clear all
Filters
3
NCT02573324
2023-05-11
Intellance1
AbbVie
Phase 3
Completed
691 enrolled
28 charts